News
German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of ...
Changing the prescribing protocol for low-dose aspirin (LDA) for preeclampsia prevention from risk-based to universal ...
14h
Pharmaceutical Technology on MSNBayer’s Eylea set for longer treatment intervals to challenge Roche’s VabysmoAn EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
2d
Zacks Investment Research on MSNBayer Begins Phase I Study on BAY 3670549 in Atrial FibrillationBayer AG BAYRY announced that it has initiated a phase I study, which is evaluating its investigational highly selective ...
Bayer meanwhile recently started a fourth phase 3 trial of elinzanetant that will test the drug's ability to treat VMS associated with endocrine therapy of breast cancer. GlobalData recently ...
Keep reading to find out about the 10 most common chronic conditions that older adults face, starting with the most common ones, and learn how to manage or even prevent them. More than 70 percent ...
Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results